5126 - 5150 of 8826 Results
Title
Year
-
OPENTitle: Defining Utility Values for Chorea Health States in Patients with Huntington’s DiseaseJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 39Issue #: 4Start Page: 1784End Page: 1793Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s12325-022-02046-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12325-022-02046-z.pdfCitation Count: 6
-
OPENTitle: Effects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 57End Page: 57Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00317-8Best OA location URL: https://www.nature.com/articles/s41531-022-00317-8.pdfCitation Count: 4
-
OPENTitle: Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc AnalysesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 2Start Page: 711End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00332-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00332-0.pdfCitation Count: 4
-
OPENTitle: Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson’s DiseaseJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 6Start Page: 2136End Page: 2136Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22062136Best OA location URL: https://www.mdpi.com/1424-8220/22/6/2136/pdf?version=1646901060Citation Count: 22
-
OPENTitle: Large-scale societal dynamics are reflected in human mood and brainJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 4646End Page: 4646Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-08569-3Best OA location URL: https://www.nature.com/articles/s41598-022-08569-3.pdfCitation Count: 6
-
OPENTitle: Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain InjuryJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 813387End Page: 813387Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2022.813387Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2022.813387/pdfCitation Count: 39
-
OPENTitle: Aquaporin-4 Polymorphisms Are Associated With Cognitive Performance in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 740491End Page: 740491Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.740491Best OA location URL: https://doi.org/10.3389/fnagi.2021.740491Citation Count: 43
-
OPENTitle: COVID-19 Vaccination Reactogenicity in Persons With Multiple SclerosisJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000001104Best OA location URL: https://nn.neurology.org/content/nnn/9/1/e1104.full.pdfCitation Count: 38
-
OPENTitle: Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson’s Disease?Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 21Start Page: 11522End Page: 11522Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms222111522Best OA location URL: https://www.mdpi.com/1422-0067/22/21/11522/pdf?version=1635236511Citation Count: 12
-
OPENTitle: Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian CohortsJournal Name: Journal of Clinical MedicinePublisher: MDPI AGVol: 10Issue #: 21Start Page: 5085End Page: 5085Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jcm10215085Best OA location URL: https://www.mdpi.com/2077-0383/10/21/5085/pdf?version=1635753758Citation Count: 14
-
OPENTitle: Interaction-Based Feature Selection Algorithm Outperforms Polygenic Risk Score in Predicting Parkinson’s Disease StatusJournal Name: Frontiers in GeneticsPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 744557End Page: 744557Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fgene.2021.744557Best OA location URL: https://www.frontiersin.org/articles/10.3389/fgene.2021.744557/pdfCitation Count: 11
-
OPENTitle: Prevalence and characteristics of the aberrant anterior tibial artery: a single-center magnetic resonance imaging study and scoping reviewJournal Name: BMC Musculoskeletal DisordersPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page: 922End Page: 922Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12891-021-04801-9Best OA location URL: https://bmcmusculoskeletdisord.biomedcentral.com/track/pdf/10.1186/s12891-021-04801-9Citation Count: 14
-
OPENTitle: Stability Evaluation of Brain Changes in Parkinson's Disease Based on Machine LearningJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 735991End Page: 735991Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2021.735991Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncom.2021.735991/pdfCitation Count: 14
-
OPENTitle: Mitochondrial Defects in Fibroblasts of Pathogenic MAPT PatientsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page: 765408End Page: 765408Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2021.765408Best OA location URL: https://doi.org/10.3389/fcell.2021.765408Citation Count: 7
- Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial2021OPENTitle: Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2408End Page: 2412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28702Best OA location URL: https://doi.org/10.1002/mds.28702Citation Count: 18
-
OPENTitle: Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 729635End Page: 729635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.729635Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.729635/pdfCitation Count: 22
-
OPENTitle: Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 109333End Page: 109333Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.109333Best OA location URL: http://www.cell.com/article/S2211124721007099/pdfCitation Count: 47
-
OPENTitle: Herpesvirus Infections and Risk of Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 20Issue #: 2-3Start Page: 97End Page: 103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000512874Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8552529Citation Count: 28
-
OPENTitle: Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 10Start Page: e2344End Page: e2344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2344Best OA location URL: https://doi.org/10.1002/brb3.2344Citation Count: 13
-
OPENTitle: Mental health in people with Parkinson’s disease during the COVID-19 pandemic: potential for targeted interventions?Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 95End Page: 95Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00238-yBest OA location URL: https://www.nature.com/articles/s41531-021-00238-y.pdfCitation Count: 20
-
OPENTitle: Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 9Start Page: 2837End Page: 2851Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab170Best OA location URL: https://academic.oup.com/brain/article-pdf/144/9/2837/40880314/awab170.pdfCitation Count: 29
-
OPENTitle: Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label StudyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 693End Page: 709Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00251-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00251-6.pdfCitation Count: 26
-
OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 14
-
OPENTitle: Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brainJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page: 7End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00509-5Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-021-00509-5Citation Count: 62
-
OPENTitle: Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s DiseaseJournal Name: DiagnosticsPublisher: MDPI AGVol: 11Issue #: 12Start Page: 2303End Page: 2303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/diagnostics11122303Best OA location URL: https://www.mdpi.com/2075-4418/11/12/2303/pdf?version=1638953319Citation Count: 14